Emerging3 activitiesProduct liability intelligence

Talc

Pharmaceutical · claims alleging talc products contributed to ovarian cancer or mesothelioma

DEFENDANT

Pharmaceutical

MDL / TRACK

See litigation status

JUDGE

Various

PLAINTIFFS

Emerging

BELLWETHER / TRIAL

TBD

SETTLEMENT STATUS

Pending

Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity

Live intelligence

AI litigation brief

Talc remains emerging with 3 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Talc: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Talc: court filing watch. Google News news on Mar 10: Talc: public coverage watch. openFDA regulatory on Mar 10: Talc: FDA regulatory alert.

Trajectory

Court filings and press coverage are both active, which points to sustained litigation pressure rather than a one-off headline cycle. 4 live sources are contributing current context.

Editorial intelligence

Editorial coverage should stay tied to source-backed developments and avoid placeholder status copy for Talc.

Generated Mar 10, 2026, 11:39 AM

PACER

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 3 minutes

Last fetch Mar 10, 2026, 11:36 AM

Next fetch Mar 10, 2026, 12:36 PM

Google News

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 4 minutes

Last fetch Mar 10, 2026, 11:35 AM

Next fetch Mar 10, 2026, 12:35 PM

FAERS

Live

Target freshness: within 15 minutes of upstream fetch.

Lag 11 minutes

Last fetch Mar 10, 2026, 11:28 AM

Next fetch Mar 10, 2026, 12:28 PM

PubMed

Live

Target freshness: within 30 minutes of upstream fetch.

Lag 21 minutes

Last fetch Mar 10, 2026, 11:18 AM

Next fetch Mar 10, 2026, 12:18 PM

3 activities detected

⚖️CourtPACER

Detected Mar 10, 2026, 11:34 AM

Talc: court filing watch

Federal Courts watchlist initialized for Talc. Captions, docket numbers, and venue context are validated before promotion.

AI Litigation Note

PACER court filing on Mar 10 for Talc. Talc: court filing watch — Federal Courts watchlist initialized for Talc. Captions, docket numbers, and venue context are validated before promotion. Monitor docket for scheduling orders, CMOs, and bellwether selections.

Generated Mar 10, 2026, 11:33 AM

Confidence 88%Published Mar 10, 2026, 11:32 AM

View Original Source →

📰NewsGoogle News

Detected Mar 10, 2026, 11:26 AM

Talc: public coverage watch

Google News monitoring is active for Talc. Public coverage is deduped against docket-linked items to avoid noisy repeats.

AI Litigation Note

Google News news on Mar 10 for Talc. Recent reporting adds public-pressure and defendant-accountability context.

Generated Mar 10, 2026, 11:25 AM

Confidence 88%Published Mar 10, 2026, 11:24 AM

View Original Source →

📜RegulatoryFDA

Detected Mar 10, 2026, 11:15 AM

Talc: FDA regulatory alert

openFDA monitoring is active for Talc. FDA safety alerts, recalls, and enforcement reports are tracked via direct API connection.

AI Litigation Note

openFDA regulatory on Mar 10 for Talc. Regulatory developments can change intake posture and motion practice quickly.

Generated Mar 10, 2026, 11:14 AM

Confidence 88%Published Mar 10, 2026, 11:13 AM

LexGenius Ranking

78High Signal

Court, news, and regulatory activity are elevated

Evidence16 / 20

Momentum16 / 20

Exposure16 / 20

Regulatory14 / 20

Legal16 / 20

Monitoring

60 min

refresh interval

Last: Mar 10, 2026, 11:27 AM

Next: Mar 10, 2026, 12:27 PM

Signal feed

activities detected

Google NewsPACERFAERSPubMed

AI Brief

Talc remains emerging with 3 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Talc: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Talc: court filing watch. Google News news on Mar 10: Talc: public coverage watch. openFDA regulatory on Mar 10: Talc: FDA regulatory alert.

Generated Mar 10, 2026, 11:39 AM

← Previous

Depo-Provera

Follows product-liability filings, drug-safety signals, and scientific reporting tied to Depo-Provera claims.

PFAS

Captures forever-chemical contamination litigation, rulemaking, and public-health reporting affecting PFAS exposure.